Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine: 50 Years of Modulating the Mind
Linda Li, Phillip E. Vlisides
Frontiers in Human Neuroscience (2016) Vol. 10
Open Access | Times Cited: 319

Showing 26-50 of 319 citing articles:

The abuse liability of ketamine: A scoping review of preclinical and clinical studies
Tuyen T. Le, Isabel Pazos Cordero, Muhammad Youshay Jawad, et al.
Journal of Psychiatric Research (2022) Vol. 151, pp. 476-496
Closed Access | Times Cited: 47
Structural insights into binding of therapeutic channel blockers in NMDA receptors
Tsung‐Han Chou, Max Epstein, Kevin Michalski, et al.
Nature Structural & Molecular Biology (2022) Vol. 29, Iss. 6, pp. 507-518
Open Access | Times Cited: 46
Ketamine; history and role in anesthetic pharmacology
Kazuyoshi Hirota, David G. Lambert
Neuropharmacology (2022) Vol. 216, pp. 109171-109171
Open Access | Times Cited: 46
Management of Postoperative Pain in Patients Following Spine Surgery: A Narrative Review
Nitin Prabhakar, Andrea L. Chadwick, Chinwe A. Nwaneshiudu, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 4535-4549
Open Access | Times Cited: 44
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A. Zarate, Gustavo Vázquez
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 853-866
Open Access | Times Cited: 42
Blood-based biomarkers of antidepressant response to ketamine and esketamine: A systematic review and meta-analysis
Gustavo C. Medeiros, Todd D. Gould, William L. Prueitt, et al.
Molecular Psychiatry (2022) Vol. 27, Iss. 9, pp. 3658-3669
Open Access | Times Cited: 40
In vivo mapping of pharmacologically induced functional reorganization onto the human brain’s neurotransmitter landscape
Andrea I. Luppi, Justine Y. Hansen, R. Adapa, et al.
Science Advances (2023) Vol. 9, Iss. 24
Open Access | Times Cited: 33
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
Local orchestration of distributed functional patterns supporting loss and restoration of consciousness in the primate brain
Andrea I. Luppi, Lynn Uhrig, Jordy Tasserie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Novel rapid treatment options for adolescent depression
Sandra Ledesma‐Corvi, Jordi Jornet-Plaza, Laura Gálvez‐Melero, et al.
Pharmacological Research (2024) Vol. 201, pp. 107085-107085
Open Access | Times Cited: 9
A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder
Muhammet Celik, Mark S. Gold, Brian Fuehrlein
Brain Sciences (2024) Vol. 14, Iss. 3, pp. 294-294
Open Access | Times Cited: 9
Hepatic adverse events associated with ketamine and esketamine: A population-based disproportionality analysis
Angela T.H. Kwan, Moiz Lakhani, Kayla M. Teopiz, et al.
Journal of Affective Disorders (2025) Vol. 374, pp. 390-396
Closed Access | Times Cited: 1
Mouse fMRI under ketamine and xylazine anesthesia: Robust contralateral somatosensory cortex activation in response to forepaw stimulation
Hyun‐Ji Shim, Won Beom Jung, Felix Schlegel, et al.
NeuroImage (2018) Vol. 177, pp. 30-44
Closed Access | Times Cited: 83
Circulating microRNAs as biomarkers for depression: Many candidates, few finalists
Heidi Yuan, David Mischoulon, Maurizio Fava, et al.
Journal of Affective Disorders (2017) Vol. 233, pp. 68-78
Closed Access | Times Cited: 82
Intraoperative ketamine administration to prevent delirium or postoperative cognitive dysfunction: A systematic review and meta‐analysis
Frédérique Hovaguimian, Chantal Tschopp, Beatrice Beck‐Schimmer, et al.
Acta Anaesthesiologica Scandinavica (2018) Vol. 62, Iss. 9, pp. 1182-1193
Open Access | Times Cited: 81
Ketamine and selective activation of parvalbumin interneurons inhibit stress-induced dendritic spine elimination
Lhotse Hei Lui Ng, Yuhua Huang, Lei Han, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Randomized Controlled Feasibility Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children with Suspected Extremity Fractures
Stacy Reynolds, Kathleen Bryant, Jonathan R. Studnek, et al.
Academic Emergency Medicine (2017) Vol. 24, Iss. 12, pp. 1430-1440
Open Access | Times Cited: 67
Ketamine: a versatile tool for anesthesia and analgesia
William A. Barrett, Michael Buxhoeveden, Sabrina Dhillon
Current Opinion in Anaesthesiology (2020) Vol. 33, Iss. 5, pp. 633-638
Closed Access | Times Cited: 67
Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder
Joanna Kryst, Paweł Kawalec, Andrzej Pilc
Expert Opinion on Pharmacotherapy (2019) Vol. 21, Iss. 1, pp. 9-20
Closed Access | Times Cited: 63
Recent Developments in Drugs for GI Endoscopy Sedation
Basavana Goudra, Gowri Gouda, P. Sambhi Mohinder
Digestive Diseases and Sciences (2020) Vol. 65, Iss. 10, pp. 2781-2788
Closed Access | Times Cited: 57
Esketamine: new hope for the treatment of treatment-resistant depression? A narrative review
Mohammed S. Salahudeen, Cameron Wright, Gregory M. Peterson
Therapeutic Advances in Drug Safety (2020) Vol. 11
Open Access | Times Cited: 57
The emergence of ketamine as a novel treatment for posttraumatic stress disorder
Adriana Feder, Sarah Rutter, Daniela Schiller, et al.
Advances in pharmacology (2020), pp. 261-286
Closed Access | Times Cited: 56
Ketamine: Neuroprotective or Neurotoxic?
Divya Choudhury, Anita E. Autry, Kimberley F. Tolias, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 47
Point-of-care electrochemical sensor for selective determination of date rape drug “ketamine” based on core-shell molecularly imprinted polymer
Shymaa S. Soliman, Amr M. Mahmoud, Mohamed R. Elghobashy, et al.
Talanta (2022) Vol. 254, pp. 124151-124151
Closed Access | Times Cited: 37
Ketamine as a therapeutic agent for depression and pain: mechanisms and evidence
Subha Subramanian, Simon Haroutounian, Ben Julian A. Palanca, et al.
Journal of the Neurological Sciences (2022) Vol. 434, pp. 120152-120152
Closed Access | Times Cited: 34

Scroll to top